Experienced in Otitis Media with Effusion

Noga Kurman

Department Of Otolaryngology Head And Neck Surgery, 
Petah Tiqwa, M, IL 
Experienced in Otitis Media with Effusion
Department Of Otolaryngology Head And Neck Surgery, 
Petah Tiqwa, M, IL 
OverviewLocationsClinical Research

Overview

Noga Kurman practices in Petah Tiqwa, Israel. Ms. Kurman is rated as an Experienced expert by MediFind in the treatment of Otitis Media with Effusion. Her top areas of expertise are Squamous Cell Skin Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Fanconi Anemia, Congenital Aplastic Anemia, and Laryngectomy.

Her clinical research consists of co-authoring 27 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Otitis Media with Effusion.

Gender
Female

Locations

Department Of Otolaryngology Head And Neck Surgery, Petah Tiqwa, M, Israel
Other Locations
Tel Aviv, TA, Israel
Haifa, HA 31096, Israel

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double-blind, Adaptive, Phase II/III Study of GSK3359609 or Placebo in Combination With Pembrolizumab for First-Line Treatment of PD-L1 Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
A Randomized, Double-blind, Adaptive, Phase II/III Study of GSK3359609 or Placebo in Combination With Pembrolizumab for First-Line Treatment of PD-L1 Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Enrollment Status: Terminated
Publish Date: July 10, 2024
Intervention Type: Drug
Study Drugs: Feladilimab, Pembrolizumab
Study Phase: Phase 3

27 Total Publications

N-Acetylcysteine Amide Is a Potential Novel Radioprotector of Salivary Gland Function.
N-Acetylcysteine Amide Is a Potential Novel Radioprotector of Salivary Gland Function.
Journal: Cancers
Published: July 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Kurman's expertise for a condition
ConditionClose
      View All 14 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile